OOIR: Observatory of International Research

Papers

(The median citation count of Prostate International is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Oncological outcomes after radical prostatectomy of localized prostate cancer: stratified by magnetic resonance imaging and risk classification	50
Does androgenic alopecia aggravate the risk of prostate cancer? Evidence from Mendelian randomization	33
The association between behavioral habits and physical health status in prostate cancer patients: a large US national health-related survey	20
Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer	19
Association between pelvic lymph node dissection and survival among patients with prostate cancer treated with radical prostatectomy	18
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer	18
Is antibiotic prophylaxis still mandatory for transperineal prostate biopsy? Results of a comparative study	17
Association between preradiation therapy prostate-specific antigen levels and radiation therapy failure after prostatectomy: a propensity score matched analysis	16
Topical antiseptic at time of transrectal ultrasound prostate biopsy is associated with fewer severe clinical infections and improves antibiotic stewardship	16
Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects	16
Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: a multiinstitutional study	16
Holmium laser enucleation of the prostate as a treatment option for patients with concurrent outlet obstruction and bladder diverticulum	15
Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign	14
Safety and efficacy of extracorporeal shockwave therapy on chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled study	14
Real-world prostate-specific antigen reduction and survival outcomes of metastatic hormone-sensitive prostate cancer patients treated with apalutamide: An observational, retrospective, and multicentre	13
Biopsy-free radical prostatectomy: a narrative review considering rationale, limitations, and current data	12
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients	12
The prevalence of dyslipidemia in patients with prostate cancer	12
The impact of obesity and sexual behavior on prostate cancer risk is mediated by testosterone levels: a mendelian randomization study and mediation analysis	12
Transurethral water vapor therapy (Rezūm) for acute urinary retention with obstructive uropathy: a prospective cohort study with one-year follow-up	11
Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures	11
The feasibility of distance to the tumor of biopsy cores to estimate the extracapsular extension	11
Evaluation of the efficiency of transurethral enucleation with bipolar energy according to prostate volume for patients with benign prostate hyperplasia	11
The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer	10
Assessing the influence of prostate tissue traits on Gallium-68 prostate-specific membrane-antigen positron-emission tomography/computed tomography: predictive factors for image positivity and locoreg	10

Efficacy of tamsulosin 0.4 mg for the treatment in male with the international Prostate Symptom Score ≥ 20 compared with tamsulosin 0.2 mg	10
Clinical implication of peri-seminal vesicle soft-tissue invasion in patients with pT3b prostate cancer	10
Time to castrate the cost? the rising expense of chemical castration for the management of prostate cancer	10
Efficacy and safety of pentosan polysulfate therapy in patients with interstitial cystitis for relief of lower urinary tract symptoms: 15-year single center experience	10
A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia	10
Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer	9
Oncologic outcomes of salvage radiotherapy and lymphadenectomy for positron emission tomography–positive lymph nodes in biochemical recurrence: A systematic review to inform treatment decisions	9
Comparing the efficacy of tadalafil and tamsulosin for managing erectile dysfunction and lower urinary tract symptoms in prostate brachytherapy patients: a prospective study	9
Negative magnetic resonance imaging cannot be used to omit an initial prostate biopsy - An ambispective study	9
A meta-analysis on the use of radiotherapy after prostatectomy: adjuvant versus early salvage radiation	8
Irreversible electroporation for prostate cancer using PSMA PET-CT	8
Comparison of the efficacy and safety of holmium laser enucleation of the prostate and prostate artery embolization: Short-term follow-up results	8
Short course of dutasteride in treatment of a refractory category IIIB chronic prostatitis (A placebo-controlled study)	8
Diagnostic performance of MRI for prediction of recurrent prostate cancer after high-intensity focused ultrasound: a systematic review and meta-analysis	8
Utility of the prostate health index density for detecting clinically significant prostate cancer in patients with negative magnetic resonance imaging findings	8
High-power holmium laser versus thulium fiber laser for endoscopic enucleation of the prostate in patients with glands larger than 80 ml: Results from the Prostate Endoscopic EnucLeation study group	8
Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® system	7
Prostate diseases and microbiome in the prostate, gut, and urine	7
Single-port and multiport robot-assisted radical prostatectomy: A meta-analysis	7
A new parameter to increase the predictive value of multiparametric prostate magnetic resonance imaging for clinically significant prostate cancer in targeted biopsies: lesion density	7
Utilization of prostate-specific membrane antigen positron emission tomography in Australia following government subsidization: Trends in primary staging and biochemical recurrence	7
Application of robotics in the treatment of benign prostatic hyperplasia: a narrative review	7
Quality-of-Life Outcomes Following Aquablation in Men with Poor Initial Quality of Life: Pooled Analysis of Five International Studies	6
Screening and validation of novel serum panel of microRNA in stratification of prostate cancer	6
Urine spermine and multiparametric magnetic resonance imaging for prediction of prostate cancer in Japanese men	6
Utility of transperineal template-guided mapping prostate biopsy in biopsy-naïve men with PI-RADS 1-2 on multiparametric magnetic resonance imaging	6
Preoperative prostatic artery embolization before transurethral resection of the prostate for prostate glands larger than 80 mL: the first randomized controlled trial	6
Extended versus standard pelvic lymph node dissection yields no difference in 3-year biochemical recurrence rates	6
Association between predictors of progression of benign prostatic hyperplasia and moderate-to-severe prostatitis-like symptoms: A propensity score–matched analysis	6
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study	6
Artificial intelligence–driven digital pathology in urological cancers: current trends and future directions	5
Initial experience of single-port robot-assisted radical prostatectomy: A single surgeon's experience with technique description	5
Comparisons of three scoring systems based on biparametric magnetic resonance imaging for prediction of clinically significant prostate cancer	5
Hematospermia does not increase the risk of prostate cancer detection in prostate biopsy	5
Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer	5
Pelvic lymph node management in prostate cancer: a narrative review	5
External validation of the cancer of the prostate risk assessment score to predict treatment failure after high-intensity focused ultrasound	5
Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study	5
Exploring the potential of ex-vivo 7-T magnetic resonance imaging on patients with clinically significant prostate cancer: visibility and size perspective	5
How many cores should be taken from each region of interest when performing a targeted transrectal prostate biopsy?	5
Robotic-assisted simple prostatectomy versus holmium laser enucleation of the prostate for large benign prostatic hyperplasia: A single-center preliminary study in Korea	5
Corrigendum to “Screening and validation of novel serum panel of microRNA in stratification of prostate cancer” [Prostate Int 11 (2023) 150–158]	5
Real-world effects of novel androgen receptor axis-targeted agents on oncological outcomes in non-metastatic castration-resistant prostate cancer: A multi-institutional retrospective study	5
Irreversible electroporation for localized prostate cancer: risk-stratified oncologic outcomes and functional preservation	4
Prognosis after radical prostatectomy in men older than 75 years: long-term results from a single tertiary center	4
Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer	4
A novel anterior approach that involves Retzius space development between the umbilical ligaments is associated with a lower incidence of postoperative inguinal hernia in robotic radical prostatectomy	4
The effect of systemic hypertension on prostatic artery resistive indices in patients with benign prostate enlargement	4
Reviving intimacy: Penile rehabilitation strategies for men after prostate cancer treatment	4
Propensity score matched analysis of functional outcome in five thousand cases of robot-assisted radical prostatectomy versus high-intensity focused ultrasound	4

The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy in clinically significant prostate cancer detection in patients with biopsy-naïve men according to PSA levels: A prop	4
Dr. Answer AI for prostate cancer: Intention to use, expected effects, performance, and concerns of urologists	4
Effects of bladder neck sparing on continence outcomes of robotic-assisted radical prostatectomy: a systemic review and metaanalysis	4
Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center	4
Detection of anterior prostate cancer using a magnetic resonance imaging-transrectal ultrasound fusion biopsy in cases with initial biopsy and history of systematic biopsies	4
Predictors of readmission and impact of same-day discharge in holmium laser enucleation of the prostate	4
Oral chemotherapeutic agents in metastatic hormone-sensitive prostate cancer: A network meta-analysis of randomized controlled trials	4
Temporal changes of PIRADS scoring by radiologists and correlation to radical prostatectomy pathological outcomes	3
Cardiovascular risks of Asian patients on androgen-receptor-targeted agents for prostate cancer: a systematic review and meta-analysis	3
How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density	3
Do bony pelvis parameters affect perioperative outcomes in open radical prostatectomy?	3
Pain relieving effect of music on patients during transrectal ultrasonography: A pilot study	3
Changes of resistance indices after medication in benign prostatic hyperplasia: a prospective study	3
Surgical management of post prostatectomy incontinence	3
Postoperative tadalafil for recovery of continence and voiding function after radical prostatectomy for prostate cancer: a single-center experience	3